Literature DB >> 19000708

Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes.

Mohit Kumar Bhutani1, Mahendra Bishnoi, Shrinivas K Kulkarni.   

Abstract

Curcumin, a yellow pigment extracted from rhizomes of the plant Curcuma longa (turmeric), has been widely used as food additive and also as a herbal medicine throughout Asia. The present study was designed to study the pharmacological, biochemical and neurochemical effects of daily administration of curcumin to rats subjected to chronic unpredictable stress. Curcumin treatment (20 and 40 mg/kg, i.p., 21 days) significantly reversed the chronic unpredictable stress-induced behavioral (increase immobility period), biochemical (increase monoamine oxidase activity) and neurochemical (depletion of brain monoamine levels) alterations. The combination of piperine (2.5 mg/kg, i.p., 21 days), a bioavailability enhancer, with curcumin (20 and 40 mg/kg, i.p., 21 days) showed significant potentiation of its anti-immobility, neurotransmitter enhancing (serotonin and dopamine) and monoamine oxidase inhibitory (MAO-A) effects as compared to curcumin effect per se. This study provided a scientific rationale for the use of curcumin and its co-administration with piperine in the treatment of depressive disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19000708     DOI: 10.1016/j.pbb.2008.10.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  60 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

Review 2.  Neurobiology of chronic mild stress: parallels to major depression.

Authors:  Matthew N Hill; Kim G C Hellemans; Pamela Verma; Boris B Gorzalka; Joanne Weinberg
Journal:  Neurosci Biobehav Rev       Date:  2012-07-07       Impact factor: 8.989

3.  Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.

Authors:  Zakiya Qualls; Dwayne Brown; Carlana Ramlochansingh; Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-01       Impact factor: 3.911

4.  The development of injectable gelatin/silk fibroin microspheres for the dual delivery of curcumin and piperine.

Authors:  Juthamas Ratanavaraporn; Sorada Kanokpanont; Siriporn Damrongsakkul
Journal:  J Mater Sci Mater Med       Date:  2013-11-02       Impact factor: 3.896

5.  Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF.

Authors:  Laura L Hurley; Luli Akinfiresoye; Evaristus Nwulia; Atsushi Kamiya; Amol A Kulkarni; Yousef Tizabi
Journal:  Behav Brain Res       Date:  2012-11-08       Impact factor: 3.332

Review 6.  Bioavailability enhancers of herbal origin: an overview.

Authors:  Kritika Kesarwani; Rajiv Gupta; Alok Mukerjee
Journal:  Asian Pac J Trop Biomed       Date:  2013-04

Review 7.  Role of microRNAs in the Therapeutic Effects of Curcumin in Non-Cancer Diseases.

Authors:  Amir Abbas Momtazi; Giuseppe Derosa; Pamela Maffioli; Maciej Banach; Amirhossein Sahebkar
Journal:  Mol Diagn Ther       Date:  2016-08       Impact factor: 4.074

Review 8.  Duality of Antidepressants and Neuroprotectants.

Authors:  Yousef Tizabi
Journal:  Neurotox Res       Date:  2015-11-27       Impact factor: 3.911

9.  An overview of curcumin in neurological disorders.

Authors:  S K Kulkarni; A Dhir
Journal:  Indian J Pharm Sci       Date:  2010-03       Impact factor: 0.975

Review 10.  Control of biogenic amines in food--existing and emerging approaches.

Authors:  Aishath Naila; Steve Flint; Graham Fletcher; Phil Bremer; Gerrit Meerdink
Journal:  J Food Sci       Date:  2010-09       Impact factor: 3.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.